Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Garay Malpartida, Humberto M ^a   Mourão, Roberta F ^a   Mantovani, Marluce ^a   Santos, Icaro A ^a   Sogayar, Mari C ^a   Goldberg, Anna C ^a,b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto de Investigação em Imunologia iii   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; INSULIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 4;

ADULT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BRAIN DEATH; CELL SURFACE; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN HOMEOSTASIS; INSULIN RELEASE; INSULIN SYNTHESIS; INSULINOMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CELL MEMBRANE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUMOR CELL LINE;

ADULT; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HOMEOSTASIS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LIPOPOLYSACCHARIDES; MALE; MICE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 79952044141     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-18     Document Type: Article

References (35)

1. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhoffer M, Orntoft T, Eizirik DL. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 2001, 276:48879-86. 10.1074/jbc.M108658200, 11687580.
2. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355:1318-30. 10.1056/NEJMoa061267, 17005949.
3. O'Gorman D, Kin T, Murdoch T, Richer B, McGhee-Wilson D, Ryan EA, Shapiro JA, Lakey JR. The standardization of pancreatic donors for islet isolations. Transplantation 2005, 80:801-6.
4. Toyama H, Takada M, Suzuki Y, Kuroda Y. Activation of macrophage-associated molecules after brain death in islets. Cell Transplant 2003, 12:27-32. 10.3727/000000003783985205, 12693661.
5. Contreras JL, Eckstein C, Smyth CA, Sellers MT, Vilatoba M, Bilbao G, Rahemtulla FG, Young CJ, Thompson JA, Chaudry IH, Eckhoff DE. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003, 52:2935-42. 10.2337/diabetes.52.12.2935, 14633854.
6. Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG. Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 2000, 49:340-5. 10.2337/diabetes.49.3.340, 10868954.
7. Bertuzzi F, Ricordi C. Prediction of clinical outcome in islet allotransplantation. Diabetes Care 2007, 30:410-7. 10.2337/dc06-1233, 17259521.
8. Sakuma Y, Ricordi C, Miki A, Yamamoto T, Pileggi A, Khan A, Alejandro R, Inverardi L, Ichii H. Factors that affect human islet isolation. Transplant Proc 2008, 40:343-5. 10.1016/j.transproceed.2007.12.019, 2614209, 18374062.
9. Melzi R, Piemonti L, Nano R, Clissi B, Calori G, Antonioli B, Marzorati S, Perseghin G, Di Carlo V, Bertuzzi F. Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release. Transplantation 2004, 78:1564-7. 10.1097/01.TP.0000144184.20085.41, 15599324.
10. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med 2006, 84:712-25. 10.1007/s00109-006-0084-y, 16924467.
11. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-95. 10.1038/ni1112, 15454922.
12. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 2005, 6:565-70. 10.1038/ni1207, 15895089.
13. Hijiya N, Miyake K, Akashi S, Matsuura K, Higuchi Y, Yamamoto S. Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide. Pathobiology 2002, 70:18-25. 10.1159/000066000, 12415188.
14. Erridge C, Burdess A, Jackson AJ, Murray C, Riggio M, Lappin D, Milligan S, Spickett CM, Webb DJ. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. Eur J Clin Invest 2008, 38:713-20. 10.1111/j.1365-2362.2008.02010.x, 18837796.
15. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA, Saad MJ. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-98. 10.2337/db06-1595, 17519423.
16. Nicola JP, Velez ML, Lucero AM, Fozzatti L, Pellizas CG, Masini-Repiso AM. Functional Toll-Like Receptor 4 Conferring Lipopolysaccharide Responsiveness Is Expressed in Thyroid Cells. Endocrinology 2008,
17. Hirata T, Osuga Y, Hirota Y, Koga K, Yoshino O, Harada M, Morimoto C, Yano T, Nishii O, Tsutsumi O, Taketani Y. Evidence for the presence of toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab 2005, 90:548-56. 10.1210/jc.2004-0241, 15509642.
18. Wolf G, Bohlender J, Bondeva T, Roger T, Thaiss F, Wenzel UO. Angiotensin II upregulates toll-like receptor 4 on mesangial cells. J Am Soc Nfephrol 2006, 17:1585-93.
19. Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell ME, Apovian CM, Freedman J, Gokce N. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008, 16:932-7. 10.1038/oby.2008.25, 18292749.
20. Vives-Pi M, Somoza N, Fernandez-Alvarez J, Vargas F, Caro P, Alba A, Gomis R, Labeta MO, Pujol-Borrell R. Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 2003, 133:208-18. 10.1046/j.1365-2249.2003.02211.x, 1808777, 12869026.
21. Parnaud G, Bosco D, Berney T, Pattou F, Kerr-Conte J, Donath MY, Bruun C, Mandrup-Poulsen T, Billestrup N, Halban PA. Proliferation of sorted human and rat beta cells. Diabetologia 2008, 51:91-100. 10.1007/s00125-007-0855-1, 17994216.
22. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57:3090-8. 10.2337/db08-0564, 2570406, 18650365.
23. Goldberg A, Parolini M, Chin BY, Czismadia E, Otterbein LE, Bach FH, Wang H. Toll-like receptor 4 suppression leads to islet allograft survival. Faseb J 2007, 21:2840-8. 10.1096/fj.06-7910com, 17475921.
24. Kiely A, Robinson A, McClenaghan NH, Flatt PR, Newsholme P. Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 beta-cell insulin secretion and signal transduction. J Endocrinol 2009, 202:365-73. 10.1677/JOE-09-0160, 19553279.
25. Ghanim H, Mohanty P, Deopurkar R, Sia CL, Korzeniewski K, Abuaysheh S, Chaudhuri A, Dandona P. Acute modulation of toll-like receptors by insulin. Diabetes Care 2008, 31:1827-31. 10.2337/dc08-0561, 2518353, 18556339.
26. Tsan MF, Gao B. Cytokine function of heat shock proteins. Am J Physiol Cell Physiol 2004, 286:C739-44. 10.1152/ajpcell.00364.2003, 15001423.
27. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000, 164:558-61.
28. Warger T, Hilf N, Rechtsteiner G, Haselmayer P, Carrick DM, Jonuleit H, von Landenberg P, Rammensee HG, Nicchitta CV, Radsak MP, Schild H. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 2006, 281:2254-53.
29. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001, 276:10229-33. 10.1074/jbc.M100099200, 11150311.
30. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 2007, 282:18265-75. 10.1074/jbc.M606352200, 17400552.
31. Hodgkinson CP, Laxton RC, Patel K, Ye S. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:2275-81. 10.1161/ATVBAHA.108.175992, 18818414.
32. Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graca-Souza AV, Bozza MT. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 2007, 282:20221-9. 10.1074/jbc.M610737200, 17502383.
33. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988, 37:413-20. 10.2337/diabetes.37.4.413, 3288530.
34. Ichii H, Inverardi L, Pileggi A, Molano RD, Cabrera O, Caicedo A, Messinger S, Kuroda Y, Berggren PO, Ricordi C. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005, 5:1635-45. 10.1111/j.1600-6143.2005.00913.x, 15943621.
35. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45. 10.1093/nar/29.9.e45, 55695, 11328886.